Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
IKNL: verdubbeling patiënten met levercel- en galwegkanker
jan 2024 | Hepatologie, Maag-darm-leveroncologie